Zhongnan Medical Journal Press

Home Results

A total of 4 result was found. Results that relate to Tislelizumab

Cost-utility analysis of tislelizumab versus sorafenib as first-line treatment for advanced unresectable hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):109-116.
1581 times 564 times

SU Zhan CHE Jinhui PEI Ruifeng

Hepatocellular carcinoma Tislelizumab Sorafenib Partition survival model Pharmacoeconomic analysis
Details
First-line treatment with tislelizumab for advanced non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):790-800.
1880 times 401 times

LI Wenyan PAN Xiding JIE Qiong LI Yuanyuan TANG Mufei

Tislelizumab Non-small cell lung cancer First-line treatment Rapid health technology assessment
Details
A case report of psoriasis-like rash caused by tislelizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1189-1195.
1346 times 308 times

LI Jie WANG Ronghua XIE Xiaolei

Tislelizumab Psoriasis-like rash Adverse drug reaction
Details
A case report of immune-related multisystem adverse reactions caused by tislelizumab

Published on Chinese Journal of Pharmacoepidemiology New Online
496 times 45 times

SONG Qiuyan TAI Qirui ZHANG Bikui LUO Zhiying SUN Bao LIU Wenhui

Tislelizumab Myasthenia gravis Myositis Myocarditis Liver function damage Immune-related adverse reaction
Details